ERIC JONASCH to Proto-Oncogene Proteins c-met
This is a "connection" page, showing publications ERIC JONASCH has written about Proto-Oncogene Proteins c-met.
Connection Strength
0.516
-
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene. 2016 05; 35(21):2687-97.
Score: 0.423
-
Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis. Eur J Cancer. 2018 11; 104:188-194.
Score: 0.033
-
Recommendations for the Management of Rare Kidney Cancers. Eur Urol. 2017 12; 72(6):974-983.
Score: 0.030
-
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017 Sep 10; 35(26):2993-3001.
Score: 0.030